Here, we have synthesized and characterized three visible light responsive terpyridine
based-Re (I)-tricarbonyl complexes;[Re (CO) 3 (ph-tpy) Cl](Retp1),[Re (CO) 3 (an-tpy) …

Using the principle of “Magic Bullet”, a cisplatin-derived platinum (IV) prodrug
heterobimetallic Pt (IV)–Ru (II) complex, cis, cis, trans-[Pt (NH3) 2Cl2 {Ru (tpy–BODIPY)(tpy …

The development of multi-functional Pt (IV) complexes as chemotherapeutic agents has
gained growing attention in medical oncology. However, the design of multi-functional tumor …

With the successive development of chemotherapy drugs, good results have been achieved
in clinical application. However, myocardial toxicity is the biggest challenge. Anthracyclines …

The relentless increase in drug resistance of platinum-based chemotherapeutics has
opened the scope for other new cancer therapies with novel mechanisms of action (MoA) …

We have red-shifted the light absorbance property of a Re (I)-tricarbonyl complex via distant
conjugation of a ferrocene moiety and developed a novel complex ReFctp,[Re (Fctp)(CO) …

Cancer phototheranostics is a new mode of precise treatment based on fluorescent and
photothermal imaging (PTI), combined with photodynamic (PDT) and photothermal therapy …

Light-induced release of cisplatin from Pt (IV) prodrugs represents a promising approach for
precise control over the antiproliferative activity of Pt-based chemotherapeutic drugs. This …

Four lanthanide complexes with 8‐hydroxyquinoline‐2‐aldehyde‐2‐hydrazinopyridine (H‐
L1), 8‐hydroxyquinoline‐2‐aldehyde‐2‐hydrazimidazole (H‐L2):[Sm (L1) 2][Sm (L1)(NO3) …

Light induced release of cisplatin from Pt (IV) prodrugs is a promising tool for precise
spatiotemporal control over the antiproliferative activity of Pt‐based chemotherapeutic drugs …